Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
66 Leser
Artikel bewerten:
(0)

Jury Awards Plaintiff Millions in Compensatory Damages for Failed Transvaginal Mesh Implant

CHICAGO, Feb. 25, 2013 /PRNewswire/ -- In a resounding victory for Plaintiff, a jury in the Superior Court of Atlantic County, N.J., reached a partial verdict totaling $3.35 million in compensatory damages for Ms. Linda Goss and against Johnson & Johnson for theirdefective transvaginal mesh implant.

Surgical mesh, which is used for transvaginal mesh surgery and bladder slings, is a medical device that is generally used to repair weakened or damaged tissue (specifically in pelvic organ prolapse (POP) or stress urinary incontinence (SUI)).

Serious Complicationshave been known to occur when the mesh moves - perforating the bladder, bowel or uterus. According to anFDA Alertfrom July 2012, serious complications such as infection, erosion of vaginal tissue, vaginal bleeding, vaginal scaring and severe pain are not rare.

In the case of Ms. Gross, a former nurse from South Dakota, the pain from the implanted device was so bad that she had trouble sitting down. In the lawsuit, Ms. Gross alleged the implant led to a variety of complications, including mesh erosion, scar tissue, inflammation and "neurologic compromise to structures and tissues."

Johnson & Johnson released the product prior to FDA approval; instead of conducting lengthy tests, the company compared the Gynecare Prolift to another one of its mesh products already on the market, Gynecare Gynemesh. Internal emails show the pharmaceutical company was aware of the failure rate during testing, disregarded the potential risks, and placed the implant on the market for sale.

As of February 25, 2013 there are more than 2,500 cases pending before Honorable Carol E. Higbee of the Superior Court of New Jersey against both Johnson & Johnson and C.R. Bard, Inc. (who sold a similar mesh product). We expect the number of lawsuits to continue to increase as more women become aware of their legal rights.

TorHoerman Lawurges women injured as a result of a transvaginal mesh implant to contact an attorney immediately to protect their legal rights.

SOURCE TorHoerman Law, LLC

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.